SUBSCRIBE
SUBSCRIBE

Soligenix

NEWS
Policy
Soligenix Receives US Patent Expanding Protection for its Ricin Toxin Vaccine, RiVax®
Soligenix, Inc. announced the allowance of a new United States patent protecting its ricin toxin vaccine, RiVax®.
February 12, 2019
 · 
9 min read
Policy
Soligenix Receives European Patent for Dusquetide and Related Innate Defense Regulator Analogs
Patent broadens protection in infectious disease, including composition of matter claims
January 23, 2019
 · 
9 min read
Maxim Group Research Report Update on Soligenix
Analyst Jason McCarthy, PhD of Maxim Group updated coverage on Soligenix, Inc. on December 6, 2018. For more information, please visit www.maximgrp.com.
December 7, 2018
 · 
1 min read
Pharm Country
Soligenix Discusses Ricin Toxin Vaccine
Dr. Oreola Donini, Senior Vice President and Chief Scientific Officer, discusses the Company’s ricin toxin vaccine with ROI-NJ.
October 5, 2018
 · 
4 min read
Load More
JOBS
IN THE PRESS
Press Releases
Soligenix, Inc. to Present at the 2024 ThinkEquity Conference
October 25, 2024
 · 
6 min read
Press Releases
Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin
October 23, 2024
 · 
20 min read
Press Releases
Soligenix Announces Partnership with Sterling Pharma Solutions
October 3, 2024
 · 
15 min read
Press Releases
Join Soligenix’s Exclusive Live Investor Webinar and Q&A Session on September 18, 2024
September 16, 2024
 · 
6 min read
Press Releases
Soligenix Receives European Patent for Improved Production of Synthetic Hypericin
September 3, 2024
 · 
15 min read
Business
Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results
August 9, 2024
 · 
9 min read
Press Releases
Strong Clinical Momentum for Soligenix’s HyBryte™ in Treating Cutaneous T-Cell Lymphoma; PCG Digital Exclusive with Dr. Brian Poligone
August 2, 2024
 · 
5 min read
Deals
Soligenix Announces Reverse Stock Split - May 31, 2024
May 31, 2024
 · 
7 min read
Deals
Soligenix Encourages Stockholders to Vote FOR Reverse Stock Split
May 23, 2024
 · 
8 min read
Pharm Country
SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference
May 21, 2024
 · 
13 min read
Load More